Pharmaxis Topical Scar Trial Featured on TV NewsThe clinical trial of Pharmaxis topical anti-fibrotic drug discovery PXS-6302 has featured on Channel 9 News. PXS-6302 is being trialed in collaboration with The University of Western Australia, led by Professor Fiona Wood AM. Having passed Phase 1a safety trials, the drug is now recruiting a longer term study in 50 patients with established scars.With the ultimate goal to “unscar the scar”, PXS-6302 aims to change the bonds within the skin scar tissue and thereby improve skin quality, elasticity and appearance.Trial results are expected by the end of the year.
Watch the Channel 9 News story here.
This is great news and perhaps we may see some approvals by the end of the year.
Pharmaxis Topical Scar Trial Featured on TV NewsThe clinical...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
